Trinity Average Payables from 2010 to 2026
| TRIB Stock | USD 0.91 0.00 0.000003% |
Average Payables | First Reported 2010-12-31 | Previous Quarter 3.8 M | Current Value 3.3 M | Quarterly Volatility 119.7 K |
Check Trinity Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Trinity Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Total Revenue of 78.3 M or Gross Profit of 35 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0019 or Days Sales Outstanding of 90.37. Trinity financial statements analysis is a perfect complement when working with Trinity Biotech Valuation or Volatility modules.
Trinity | Average Payables | Build AI portfolio with Trinity Stock |
Latest Trinity Biotech's Average Payables Growth Pattern
Below is the plot of the Average Payables of Trinity Biotech plc over the last few years. It is the average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers. Trinity Biotech's Average Payables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Trinity Biotech's overall financial position and show how it may be relating to other accounts over time.
| Average Payables | 10 Years Trend |
|
Average Payables |
| Timeline |
Trinity Average Payables Regression Statistics
| Arithmetic Mean | 3,330,374 | |
| Geometric Mean | 3,328,509 | |
| Coefficient Of Variation | 3.59 | |
| Mean Deviation | 54,557 | |
| Median | 3,299,228 | |
| Standard Deviation | 119,693 | |
| Sample Variance | 14.3B | |
| Range | 494.9K | |
| R-Value | 0.34 | |
| Mean Square Error | 13.5B | |
| R-Squared | 0.12 | |
| Significance | 0.18 | |
| Slope | 8,093 | |
| Total Sum of Squares | 229.2B |
Trinity Average Payables History
About Trinity Biotech Financial Statements
Trinity Biotech stakeholders use historical fundamental indicators, such as Trinity Biotech's Average Payables, to determine how well the company is positioned to perform in the future. Although Trinity Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Trinity Biotech's assets and liabilities are reflected in the revenues and expenses on Trinity Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Trinity Biotech plc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Average Payables | 3.8 M | 3.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:Check out the analysis of Trinity Biotech Correlation against competitors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Trinity Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.77) | Earnings Share (1.80) | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
Trinity Biotech plc's market price often diverges from its book value, the accounting figure shown on Trinity's balance sheet. Smart investors calculate Trinity Biotech's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Trinity Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.